Antonio Giordano to Chemotherapy, Adjuvant
This is a "connection" page, showing publications Antonio Giordano has written about Chemotherapy, Adjuvant.
Connection Strength
0.084
-
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial. Int J Med Sci. 2021; 18(10):2245-2250.
Score: 0.047
-
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting. J Cell Physiol. 2018 Mar; 233(3):2313-2323.
Score: 0.037